GNOM Holdings
52 holdings in the fund's latest file; the data source updated it on Oct 7, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | MODERNA INC | 9.54% | 51,197 | $9.6M |
| 2 | TWIST BIOSCIENCE CORP | 7.25% | 43,703 | $7.3M |
| 3 | 10X GENOMICS INC-CLASS A | 6.74% | 84,095 | $6.8M |
| 4 | ILLUMINA INC | 5.93% | 21,813 | $6.0M |
| 5 | NATERA INC | 5.45% | 13,696 | $5.5M |
| 6 | GUARDANT HEALTH INC | 5.39% | 31,781 | $5.4M |
| 7 | GENSCRIPT BIOTECH CORP (1548.HK) | 5.25% | 844,018 | $5.3M |
| 8 | BIO-TECHNE CORP | 3.50% | 48,587 | $3.5M |
| 9 | VERTEX PHARMACEUTICALS INC | 3.25% | 6,506 | $3.3M |
| 10 | QIAGEN N.V. (QGEN) | 3.23% | 71,219 | $3.3M |
| 11 | BIOMARIN PHARMACEUTICAL INC | 2.94% | 52,565 | $3.0M |
| 12 | CRISPR THERAPEUTICS AG | 2.71% | 50,453 | $2.7M |
| 13 | VERACYTE INC | 2.57% | 57,872 | $2.6M |
| 14 | BIONTECH SE-ADR | 2.49% | 26,216 | $2.5M |
| 15 | CARIS LIFE SCIENCES INC | 2.44% | 89,498 | $2.5M |
| 16 | ARROWHEAD PHARMACEUTICALS IN | 2.35% | 38,502 | $2.4M |
| 17 | PRAXIS PRECISION MEDICINES I | 2.35% | 8,441 | $2.4M |
| 18 | CAREDX INC | 2.16% | 33,996 | $2.2M |
| 19 | LEGEND BIOTECH CORP-ADR | 2.04% | 109,769 | $2.1M |
| 20 | ELI LILLY & CO | 1.76% | 1,534 | $1.8M |
| 21 | BEAM THERAPEUTICS INC | 1.73% | 69,091 | $1.7M |
| 22 | GILEAD SCIENCES INC | 1.53% | 10,707 | $1.5M |
| 23 | BILLIONTOONE INC CL A | 1.46% | 14,691 | $1.5M |
| 24 | GENEDX HOLDINGS CORP | 1.36% | 19,132 | $1.4M |
| 25 | SAREPTA THERAPEUTICS INC | 1.28% | 74,146 | $1.3M |
Sector Weights
- Healthcare: 99.72%
- Technology: 0.28%
Country Weights
- United States: 84.27%
- Hong Kong: 5.25%
- Netherlands: 4.17%
- Switzerland: 2.71%
- Germany: 2.49%
- United Kingdom: 1.14%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.